Pulmonary Embolism (PE) to Chronic Thromboembolic Pulmonary Disease (CTEPD): Findings from a Survey of UK Physicians
Advances in Respiratory Medicine · 2024
DOI: 10.3390/arm92010007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Respiratory Medicine, 2024. Verfasst von Joanna Pepke-Zaba und 4 weiteren Autor:innen. Beteiligte Einrichtung: Pulmonary Vascular Diseases Unit, National Pulmonary Hypertension Service, Royal Papworth Hospital, Cambridge CB2 0AY, UK. Hauptthemen laut MEDLINE: Pulmonary Embolism, Physicians, Cardiology. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Janssen (Switzerland), Janssen-Cilag UK.
Abstract (Originalsprache)
Chronic thromboembolic pulmonary disease (CTEPD) is a complication of pulmonary embolism (PE). We conducted an online survey of UK PE-treating physicians to understand practices in the follow-up of PE and awareness of CTEPD. The physicians surveyed (N = 175) included 50 each from cardiology, respiratory and internal medicine, plus 25 haematologists. Most (89%) participants had local guidelines for PE management, and 65% reported a PE follow-up clinic, of which 69% were joint clinics. Almost half (47%) had a protocol for the investigation of CTEPD. According to participants, 129 (74%) routinely consider a diagnosis of CTEPD and 97 (55%) routinely investigate for CTEPD, with 76% of those 97 participants investigating in patients who are symptomatic at 3 months and 22% investigating in all patients. This survey demonstrated variability in the follow-up of PE and the awareness of CTEPD and its investigation. The findings support the conduct of a national audit to understand the barriers to the timely detection of CTEPD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pulmonary Vascular Diseases Unit, National Pulmonary Hypertension Service, Royal Papworth Hospital, Cambridge CB2 0AY, UK.
- National Pulmonary Hypertension Service, Hammersmith Hospital, London W12 0HS, UK.
- Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield S10 2JF, UK.
- Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, NIHR Biomedical Research Centre, Sheffield S10 2RX, UK.
- Medical Affairs Department, Janssen-Cilag Ltd., High Wycombe HP12 4EG, UK.
- Scottish Pulmonary Vascular Unit, Golden Jubilee National Hospital, Glasgow G81 4DY, UK.
ORCID-Profile: Joanna Pepke-Zaba, David G Kiely
Förderung
- Janssen (Switzerland)
- Janssen-Cilag UK
Zitieren
APA
Pepke-Zaba, J., Howard, L., Kiely, D. G., Sweeney, S., & Johnson, M. (2024). Pulmonary Embolism (PE) to Chronic Thromboembolic Pulmonary Disease (CTEPD): Findings from a Survey of UK Physicians. Advances in Respiratory Medicine. https://doi.org/10.3390/arm92010007
Vancouver
Pepke-Zaba J, Howard L, Kiely DG, Sweeney S, Johnson M. Pulmonary Embolism (PE) to Chronic Thromboembolic Pulmonary Disease (CTEPD): Findings from a Survey of UK Physicians. Advances in Respiratory Medicine. 2024. doi:10.3390/arm92010007
BibTeX
@article{PepkeZaba2024,
author = {Pepke-Zaba, Joanna and Howard, Luke and Kiely, David G and Sweeney, Shruti and Johnson, Martin},
title = {Pulmonary Embolism (PE) to Chronic Thromboembolic Pulmonary Disease (CTEPD): Findings from a Survey of UK Physicians},
journal = {Advances in Respiratory Medicine},
year = {2024},
doi = {10.3390/arm92010007}
}
EUVIMED